Biogen Inc. - BIIB (NASDAQ-GS)

342.41
2.03 (-0.59%)
Quotes delayed 15 mins. Currently January 20, 2018 12:09:50 AM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Biogen Idec develops and markets therapeutics for neurological disorders, multiple sclerosis and Crohn's disease

Key Financials

Day Range:341.82 - 347.57
52 Week Range:244.28 - 348.84
Open:347.57
Shares:211.48M
Market Cap:72.41B
EPS:16.33
P/E Ratio:21.10
Div Yield:--
Performance
Previous close
No Chart Available
Purchase BIIB in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of BIIB not only as a single stock, but also as part of a motif.
Professional Motifs with BIIB
Biotech Breakthroughs
Biotech Breakthroughs 14.9% 1 YR RTN Biotech firms are breathing new life into hope for cures for complex diseases like cancer, arthritis and AIDS.
View all professional motifs with BIIB
What Others Think About BIIB
Brian Shannon
18 11
BiotechBioPharma
J.P. Morgan Notebook Day 1: Tax Reform At Last, Allergan's Job Cuts, Teva Turnaround, Biogen's Cash, And Getting FD… twitter.com/i/web/status/9…
TopTickers
RT @AmericanBanking : Biogen Inc $BIIB Expected to Earn Q4 2018 Earnings of $6.41 Per Share americanbankingnews.com/?p=5637302 #stocks
1
Week Herald
Biogen $BIIB Receiving Somewhat Favorable Press Coverage, Analysis Finds weekherald.com/?p=1134213
Week Herald
Biogen $BIIB Earns Outperform Rating from Citigroup weekherald.com/?p=1133944
TopTickers
RT @RatingsNetwork : Oppenheimer Raises Biogen Q4 2018 Earnings Estimates to $6.41 EPS (Previously $5.74). zpr.io/nsxZ7 $BIIB #BI…
1
US Banking News
Biogen Inc $BIIB Expected to Earn Q4 2018 Earnings of $6.41 Per Share americanbankingnews.com/?p=5637302 #stocks
1
Related Companies Within The Biotechnology Sector
TIG
TiGenix - 41.94
TIG
Amgen Inc. - 189.28
AMGN
GILD
CELG
SHPG
Shire plc - 144.99
SHPG